When will the announced personnel changes at Novo Nordisk Pharma Ltd. take effect?

The personnel changes at Novo Nordisk Pharma Ltd. will take effect on March 1, 2026, as officially announced by the company.

What is Ryo Kato's new position at Novo Nordisk Pharma Ltd. effective March 1, 2026?

Ryo Kato's new position is Head of Healthcare Policy and External Affairs Division, effective March 1, 2026, at Novo Nordisk Pharma Ltd.

What was Ryo Kato's former role before his promotion at Novo Nordisk Pharma Ltd.?

Ryo Kato's former role was Head of Public Affairs Department within the Healthcare Policy and External Affairs Division at Novo Nordisk Pharma Ltd.

Who has been appointed as Director of the Corporate Affairs Department at Novo Nordisk Pharma Ltd.?

Junko McMaster has been appointed Director of the Corporate Affairs Department at Novo Nordisk Pharma Ltd., effective March 1, 2026.

How many countries does Novo Nordisk employ people in, and what is the approximate number of employees?

Novo Nordisk employs approximately 68,800 people across 80 countries, according to the company's official information provided in the announcement.

Personnel Announcement

Published Mar 30, 2026 7:00 PM ・ Updated Jun 17, 2026 8:20 AM ・ 2 min read ・ Source: PR TIMES

Novo Nordisk Pharma has announced new personnel appointments effective March 1, 2026. Ryo Kato has been appointed as Head of the Healthcare Policy and External Affairs Division, and Junko McMaster has been appointed as Director of the Corporate Affairs Department.

Novo Nordisk Pharma Ltd. (President: Keisuke Kotani, Headquarters: Chiyoda-ku, Tokyo; hereinafter "Novo Nordisk Pharma") hereby announces the following personnel changes.

① Personnel Changes (Effective March 1, 2026) Name New Position Former Position Ryo Kato Head of Healthcare Policy and External Affairs Division Head of Public Affairs Department, Healthcare Policy and External Affairs Division

Name New Position Former Position Junko McMaster Director, Corporate Affairs Department —

About Novo Nordisk Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, building upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs approximately 68,800 people in 80 countries and markets its products in around 170 countries. Novo Nordisk Pharma Ltd., the Japanese subsidiary, was established in 1980. For more information, visit our website at www.novonordisk.co.jp

FACT BOX

Source: PR TIMES
Category: personnel

Personnel Announcement

⚡ Key Points

FACT BOX

Editorial & Verification Standards

FAQ

Cite this article — HOW TO CITE

AI CRAWLER ACTIVITY